Aligos Therapeutics, Inc.

NASDAQ:ALGS

11.44 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -131.211-87.679-96.046-128.332-108.543-52.264-13.933
Depreciation & Amortization 1.5953.0693.6753.7783.3252.2991.291
Deferred Income Tax 00000.530-0.11
Stock Based Compensation 8.45212.65214.69313.4572.9750.7520.179
Change In Working Capital -4.955-9.525-1.552-4.65116.0633.6714.885
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0.054-2.2191.722-0.313-0.130.3852.977
Other Working Capital -5.009-7.306-3.274-4.33816.1933.2861.908
Other Non Cash Items 45.3762.486-0.1590.08611.387-1.2251.639
Operating Cash Flow -80.743-78.997-79.389-115.662-74.263-46.767-6.049
Investing Activities:
Investments In Property Plant And Equipment -0.13-0.019-0.943-0.892-2.064-2.786-2.516
Acquisitions Net 0025.35-3.914-34.819-9.5770
Purchases Of Investments -108.149-0.011-104.265-19.086-45.281-70.423-66.773
Sales Maturities Of Investments 9045.01178.9152380.1800
Other Investing Activites 00-25.353.91434.8199.577-72.843
Investing Cash Flow -18.27944.981-26.2933.02232.7556.791-69.289
Financing Activities:
Debt Repayment -0.083-0.096-0.061-0.079-0.058-0.0435
Common Stock Issued 017.4430.0278.584155.54285.5750.002
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.43870.9810.2250.1724085.57594.883
Financing Cash Flow 0.35588.3280.16478.677192.34885.53299.885
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -98.66754.312-105.518-33.963150.8445.55624.547
Cash At End Of Period 37.107135.77481.462186.98220.94370.10324.547